EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 234 participants.

Also called NCT05429476

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 234 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05429476
Other papers using this trial's data
  • Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours The New England journal of medicine, 2025-04-03 DOI, PubMed 40174223

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05429476. Randomized; double masking; primary purpose treatment. Start 2022-08-17 (actual); primary completion 2024-08-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
Condition
Stroke, Acute Ischemic
Intervention (Drug)
Tissue Plasminogen Activator (Alteplase)
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct05429476
Content hash
0d73bf27ccac8ec99161abecc469b945e309c49fdd6988ab56bda9fb8862af30